Tema ETF Trust - Tema Luxury ETF (LUX)
- Previous Close
22.32 - Open
22.18 - Bid --
- Ask --
- Day's Range
22.18 - 22.30 - 52 Week Range
18.54 - 24.56 - Volume
2,655 - Avg. Volume
1,376 - Net Assets 2.54M
- NAV 22.34
- PE Ratio (TTM) 22.99
- Yield 2.94%
- YTD Daily Total Return 1.29%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.75%
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in common and preferred stocks of publicly listed companies that are contained within a recognized global luxury index, such as the S&P 500 Global Luxury Index or other comparable luxury index. The fund is non-diversified.
Tema Global Limited
Fund Family
Consumer Cyclical
Fund Category
2.54M
Net Assets
2023-05-10
Inception Date
Performance Overview: LUX
View MoreTrailing returns as of 6/3/2025. Category is Consumer Cyclical.
People Also Watch
Holdings: LUX
View MoreTop 10 Holdings (64.79% of Total Assets)
Sector Weightings
Recent News: LUX
View More
Research Reports: LUX
View MoreCooper Earnings: Lens Market Weakness Amid Macro Challenges, but Cooper's Numbers Show Resilience
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
RatingPrice TargetSharper Focus on Beverage, Retail, and Digital Platform Should Help Femsa Ride Consumption Tailwinds
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.
RatingPrice TargetCooper Earnings: Lens Market Weakness Amid Macro Challenges, but Cooper's Numbers Show Resilience
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
RatingPrice TargetLowering target price to $85.00
COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $85.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target